Brussels, 12/11/2008 (Agence Europe) - On Wednesday 12 November, the European Commission approved the proposed acquisition of Applied Biosystems by Invitrogen, both of the US and both with a significant presence in the European Economic Area. The Commission's investigation showed that in many of the markets where both Invitrogen and Applied Biosystems are present, their products do not directly compete but are complementary. The investigation focussed on nucleic acid amplification. This...